The value of biomarkers as diagnostic tool in Obstructive Sleep Apnea

Completed

• Conditions: Sleepapnea; stop breathing; 10046304

• Registration Number: NL-OMON49507
• Lead Sponsor: OLVG

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 18 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 400

Inclusion Criteria

- 18 years and older
- Diagnosed with OSA confirmed by a PSG (AHI*30 events per hour)

Exclusion Criteria

- Central sleep apnea syndrome (>50% of central apneas)
- Inability to provide informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Changes in the selected biomarkers before and after OSA treatment.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Changes in AHI and subjective outcomes correlated to changes in biomarkers.</p><br>